You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

POLA network

Showing 1 - 25 of 2,689
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma, Brain Cancer Trial in France (Nivolumab)

Completed
  • High Grade Glioma
  • Brain Cancer
  • Bordeaux, France
  • +6 more
Dec 13, 2021

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Proteomic Characterization of Aggressive Oligodendrogliomas

Recruiting
  • Oligodendroglioma
  • Proteomic analysis
  • Bron, France
  • +1 more
Apr 12, 2021

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Linz, Austria
  • +17 more
Mar 22, 2023

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Venetoclax, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • New York, New York
  • +19 more
Aug 17, 2022

Gastric Cancer, Lymph Node Metastasis Trial in Lublin (Sentinel Node Assessment, Staging laparoscopy, Gastroscopy with

Recruiting
  • Gastric Cancer
  • Lymph Node Metastasis
  • Sentinel Node Assessment
  • +2 more
  • Lublin, Poland
    Medical University of Lublin
Jan 31, 2023

Amyotrophic Lateral Sclerosis Trial in Canada, United States (MN-166, )

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Orange, California
  • +23 more
Jan 24, 2023

Orelabrutinib in Combination With Standard Treatment Regimen for

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Aug 23, 2023

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Diffuse Large B Cell Lymphoma Trial (Polatuzumab Vedotin)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Polatuzumab Vedotin
  • (no location specified)
May 3, 2022

Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)

Not yet recruiting
  • Subjective Cognitive Decline
  • Mecamylamine Challenge
  • Placebo Comparator Challenge
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 15, 2023

Brain Stimulation for Parkinson's Disease With Cognitive

Recruiting
  • Parkinson Disease
  • Cognitive Impairment
  • Deep Brain Stimulation(DBS) and Transcranial Magnetic Stimulation(TMS)
  • Tianjin, Tianjin, China
    Tianjin Huanhu Hospital
Oct 14, 2023

Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)

Not yet recruiting
  • Cervical Cancer
  • Game Changers for Cervical Cancer Prevention
  • (no location specified)
Aug 17, 2023

Eating Disorders, Eating Disorder Symptom Trial in Louisville (Personalized Intervention)

Active, not recruiting
  • Eating Disorders
  • Eating Disorder Symptom
  • Personalized Intervention
  • Louisville, Kentucky
    University of Louisville
Dec 21, 2022

Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)

Recruiting
  • Subjective Cognitive Decline
  • Mecamylamine Challenge
  • Placebo Comparator Challenge
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Dec 19, 2022

Helix Research Network

Recruiting
  • Genetic Predisposition to Disease
  • Genetics Disease
  • Exome sequencing
  • Bloomington, Minnesota
  • +3 more
Sep 25, 2023

Autism Spectrum Disorder Trial (active iTBS, sham iTBS)

Not yet recruiting
  • Autism Spectrum Disorder
  • active iTBS
  • sham iTBS
  • (no location specified)
Feb 16, 2023

Perioperative Cognitive Test Network Platform for Monitoring

Not yet recruiting
  • Perioperative Neurocognitive Disorders
    • (no location specified)
    Sep 13, 2023

    Brain Networks in Moyamoya Disease Patients Under Anesthesia

    Not yet recruiting
    • Moyamoya Disease
      • Beijing, Beijing, China
        Beijing Tiantan Hospital, Capital Medical University
      Sep 11, 2023

      Functional Neurological Disorder Trial (Psilocybin)

      Not yet recruiting
      • Functional Neurological Disorder
      • (no location specified)
      Feb 3, 2023

      Drug Resistant Epilepsy Trial (Advanced MRI)

      Not yet recruiting
      • Drug Resistant Epilepsy
      • Advanced MRI
      • (no location specified)
      Sep 22, 2023

      Healthy Trial in Bern (Auditory neurofeedback, Tactile neurofeedback, Auditory and tactile neurofeedback)

      Not yet recruiting
      • Healthy
      • Auditory neurofeedback
      • +3 more
      • Bern, Switzerland
        Division of Neurorehabilitation, Department of Neurology, Insels
      Feb 8, 2023